Manufacturers of vaginal contraceptives "encouraged" to evaluate STD prevention.
This article was originally published in The Tan Sheet
Executive Summary
OTC VAGINAL CONTRACEPTIVE MANUFACTURERS "ENCOURAGED" TO EVALUATE STD (sexually transmitted disease) prevention in the Feb. 3 tentative final monograph on the product class. The TFM states that FDA "strongly encourages manufacturers to evaluate these products for use in the prevention of infectious diseases" because the "identification of safe and effective products to prevent the transmission of HIV and other STDs is a high-priority health concern."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: